Пресс-релизы
Aug
Jul
- USFDA lifts import alert from Dr. Reddy’s Chemical Manufacturing Facility at Cuernavaca, Mexico
- Dr. Reddy’s Q1 FY13 Financial Results: Q1 FY13 Revenues at₹25.4 billion, YoY growth of 28%
- Dr. Reddy’s Q1 FY13 Financial Results: Q1 FY13 Revenues at₹25.4 billion, YoY growth of 28%
- Dr. Reddy’s announces the Launch of Atorvastatin Calcium Tablets
- Dr. Reddy's to release Q1 FY13 results on July 19, 2012 Earnings call slated for July 19, 6.30 PM IST / 9.00 AM EST
- Dr. Reddy’s announces the launch of Ibandronate Sodium tablets
Feb
